Literature DB >> 10425273

P53 codon 72Arg polymorphism is not a risk factor for carcinogenesis in the chinese.

N M Wang1, C H Tsai, K T Yeh, S J Chen, J G Chang.   

Abstract

The potential association of distinct polymorphism of the tumor suppressor gene p53, with an increased susceptibility to malignant transformation has been reported for various cancers. A polymorphism at codon 72 of p53 results in translation to either arginine (p53Arg) or proline (p53Pro), and recent study showed that Caucasian women with arginine form of p53 are more susceptible to HPV-associated carcinoma of the cervix. To examine whether arginine 72 could be a significant risk factor for tumor development, we used a PCR-based assay to analyze p53 genotypes of patients for several types of carcinoma. No significant difference in the frequency of p53Arg was found between normal and cancer patients, the results showed that the individuals homozygous for arginine variant were not at increased risk for cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10425273

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  12 in total

1.  Novel splice variants of cyclin E with altered substrate specificity.

Authors:  D C Porter; K Keyomarsi
Journal:  Nucleic Acids Res       Date:  2000-12-01       Impact factor: 16.971

2.  Distributions of p53 codon 72 polymorphism in primary open angle glaucoma.

Authors:  H-J Lin; W-C Chen; F-J Tsai; S-W Tsai
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

3.  p53 Pro72Arg polymorphism and prostate cancer in men of African descent.

Authors:  L Ricks-Santi; T Mason; V Apprey; C Ahaghotu; A McLauchlin; D Josey; G Bonney; G M Dunston
Journal:  Prostate       Date:  2010-12-01       Impact factor: 4.104

4.  Association of the p53 or GSTM1 polymorphism with the risk of nasopharyngeal carcinoma: A meta-analysis.

Authors:  Muyun Wu; Shujing Huang; Dong Liu; Miao Peng; Fan Yang; Xicheng Wang
Journal:  Mol Clin Oncol       Date:  2015-12-08

5.  TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis.

Authors:  Jing-Jun Wang; Yuan Zheng; Liang Sun; Li Wang; Peng-Bo Yu; Jian-Hua Dong; Lei Zhang; Jing Xu; Wei Shi; Yu-Chun Ren
Journal:  Mol Biol Rep       Date:  2010-12-08       Impact factor: 2.316

6.  Association of specific genotype and haplotype of p53 gene with cervical cancer in India.

Authors:  S Mitra; C Misra; R K Singh; C K Panda; S Roychoudhury
Journal:  J Clin Pathol       Date:  2005-01       Impact factor: 3.411

7.  p53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women.

Authors:  M Meftah El khair; M M Ennaji; R El kebbaj; R Ait Mhand; M Attaleb; M El Mzibri
Journal:  Med Oncol       Date:  2009-09-23       Impact factor: 3.064

Review 8.  "P53 codon 72 single base substitution in viral hepatitis C and hepatocarcinoma incidences".

Authors:  Emad F Eskander; Ahmed A Abd-Rabou; Shaymaa M M Yahya; Ashraf El Sherbini; Mervat S Mohamed; Olfat G Shaker
Journal:  Indian J Clin Biochem       Date:  2013-04-04

9.  P53 codon 11, 72, and 248 gene polymorphisms in endometriosis.

Authors:  Yao-Yuan Hsieh; Chich-Sheng Lin
Journal:  Int J Biol Sci       Date:  2006-07-12       Impact factor: 6.580

10.  Identification of differential plasma miRNA profiles in Chinese workers with occupational lead exposure.

Authors:  Ming Xu; Zhengmin Yu; Feifei Hu; Hongbing Zhang; Lixin Zhong; Lei Han; Yan An; Baoli Zhu; Hengdong Zhang
Journal:  Biosci Rep       Date:  2017-10-31       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.